REGN vs VIRT
Regeneron Pharmaceuticals Inc (REGN) versus Virtu Financial, Inc. (VIRT) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Virtu Financial, Inc. (VIRT) is a capital markets company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported VIRT revenue for 2024-12-31 was $2.88B. Net income was $534.5M. Revenue was up 25.4% from 2023-12-31 to 2024-12-31. VIRT currently screens at market cap $6.78B and trailing P/E 12.7.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. VIRT currently screens at market cap $6.78B and trailing P/E 12.7.
Not investment advice. Open the REGN and VIRT stock pages for the full models.
Not investment advice.